Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Avian Influenza Cooperative Research Centers-Studies at the Human-Animal Interface, Request for Applications (RFA) #CI06-009; and Non-Pharmaceutical Interventions for Pandemic Influenza, RFA #CI06-010

---
identifier: "/us/fr/E6-11018"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Avian Influenza Cooperative Research Centers-Studies at the Human-Animal Interface, Request for Applications (RFA) #CI06-009; and Non-Pharmaceutical Interventions for Pandemic Influenza, RFA #CI06-010"
title_number: 0
title_name: "Federal Register"
section_number: "E6-11018"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Avian Influenza Cooperative Research Centers-Studies at the Human-Animal Interface, Request for Applications (RFA) #CI06-009; and Non-Pharmaceutical Interventions for Pandemic Influenza, RFA #CI06-010"
positive_law: false
currency: "2006-07-13"
last_updated: "2006-07-13"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E6-11018"
document_type: "notice"
publication_date: "2006-07-13"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "71 FR 39683"
fr_volume: 71
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Avian Influenza Cooperative Research Centers—Studies at the Human-Animal Interface, Request for Applications (RFA) #CI06-009; and Non-Pharmaceutical Interventions for Pandemic Influenza, RFA #CI06-010

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* “Avian Influenza Cooperative Research Centers—Studies at the Human-Animal Interface,” Request for Applications (RFA) #CI06-009; and “Non-pharmaceutical Interventions for Pandemic Influenza,” RFA #CI06-010.

*Times and Dates:* 8 a.m.-8:30 a.m., August 17, 2006 (Open).

8:30 a.m.-4 p.m., August 17, 2006 (Closed).

8 a.m.-8:30 a.m., August 18, 2006 (Open).

8:30 a.m.-4 p.m., August 18, 2006 (Closed).

*Place:* Sheraton Gateway Atlanta Airport Hotel, 1900 Sullivan Road, Atlanta, GA 30337, Telephone Number 770.997.1100.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to RFA #CI06-009, “Avian Influenza Cooperative Research Centers—Studies at the Human-Animal Interface”; and RFA #CI06-010, “Non-pharmaceutical Interventions for Pandemic Influenza.”

*For Further Information Contact:* Felix Rogers, PhD, M.P.H., Scientific Review Administrator, National Immunization Program, CDC, 1600 Clifton Road, NE., Mailstop E-05, Atlanta, GA 30333, Telephone Number 404.639.6101.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: July 6, 2006.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.